Session Information

HomeProgramSession Information ▶ Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis Programs
Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis Programs

2020-virtual-banner.jpg


The following programs are related to Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis and available on-demand through Nov. 10.




Clinical and Scientific Sessions

Clinical and Scientific Sessions


ATS Virtual features programming designed just for you! Here is a list of all Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis sessions that await. More details on the sessions below can be found on the Clinical and Scientific Sessions page.



A1

Clinical Year in Review 1

  • ILD
  • NPPV and Oxygen Delivery
  • Cystic Fibrosis
  • ARDS

C1

Clinical Year in Review 3

  • Lung Cancer
  • Rare Lung Disease
  • General Critical Care
  • Lung Transplantation

B11

Beyond DNA: The Unseen Genome and Novel Omics Approaches to Pulmonary Hypertension

B83

Early Detection and Diagnosis of Idiopathic Pulmonary Fibrosis

B86

Delivery of Pulmonary Rehabilitation in the Face of Social and Health Inequality: Can We Bridge the Gap?

C91

Integrative Genomics Strategies for Complex Respiratory Diseases




Virtual Industry Programs

Virtual Industry Programs


Expand your ATS Virtual learning experience with these Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis-focused Industry Programs. More details on the programs below can be found on the Virtual Industry Programs page.



Optimizing the Care of Patients with Progressive-Fibrosing Interstitial Lung Disease: Applying the Latest Data

A non-CME educational program sponsored by Vindico Medical Education and supported by a grant from Boehringer Ingelheim Pharmaceuticals, Inc.




Virtual Exhibits

Virtual Exhibits


Explore the ATS Virtual Exhibit Hall, where you can engage with exhibitors on hot topics, the latest product launches and services, and much more! Stop by these exhibitors to learn more about the latest in Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis:

 

4DMedical
Bayer
Boehringer Ingelheim Pharmaceuticals, Inc.
Coreline Soft
CSL Behring
ECO PHYSICS
eResearch Technology Inc. (ERT)
Fisher & Paykel Healthcare
Genentech, Inc.
Hermansky-Pudlak Network Inc.
Insmed Incorporated
Polarean, Inc.
Pulmonary Fibrosis Foundation
United Therapeutics
Veracyte, Inc.
Vitalograph
ZEPHYRx

 


 

You can also access:

 

expert-chat200.png

Expert Chats

Missed the Experts? Recordings of the Expert Chats on clinical and scientific topics that took place August 5-10 are available through November 10.

Virtual Quest

Virtual Quest

From Aug. 6 – Nov. 10, we are launching a set of questions every Tuesday pertaining to exhibitors, their products or services, or their related disease areas. Answer correctly and be entered into a weekly prize drawing. Questions vary throughout the conference with numerous opportunities to win (each person can only win once).

 


 

networking

Networking Opportunities

ATS 2020 Virtual offers a variety of networking opportunities for attendees!

ePosters

ePosters

ePosters of original research of accepted 2020 abstracts.